RFL Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-0.710.0% YoY
Profit margin0.0%REAL ESTATE
Market cap$136.8MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
1.75
P/S (TTM)
117.59
EV/EBITDA
5.39

Profitability & growth

ROE (TTM)
-41.4%
Operating margin
-3154.0%
Revenue growth YoY
174.0%
Dividend yield
Beta
0.54
Last earnings
Jun 10, 2026 · Reported $-0.08
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Rafael Holdings, Inc.

Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
520 BROAD STREET, NEWARK, NJ
Fiscal year end
July
Latest quarter
Apr 30, 2026
Market cap$136.8M
Shares outstanding$51.2M
52W high$2.80
52W low$1.12

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer